CN107714685A - 甜菜碱在修复酒精对动物胚胎的损伤中的应用 - Google Patents
甜菜碱在修复酒精对动物胚胎的损伤中的应用 Download PDFInfo
- Publication number
- CN107714685A CN107714685A CN201710897319.2A CN201710897319A CN107714685A CN 107714685 A CN107714685 A CN 107714685A CN 201710897319 A CN201710897319 A CN 201710897319A CN 107714685 A CN107714685 A CN 107714685A
- Authority
- CN
- China
- Prior art keywords
- ethanol
- animal
- embryo
- glycine betaine
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 406
- 210000001161 mammalian embryo Anatomy 0.000 title claims abstract description 84
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 title claims abstract description 82
- 229960003237 betaine Drugs 0.000 title claims abstract description 76
- 241001465754 Metazoa Species 0.000 title claims abstract description 41
- 230000006378 damage Effects 0.000 title claims abstract description 36
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 35
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000019152 folic acid Nutrition 0.000 claims abstract description 18
- 239000011724 folic acid Substances 0.000 claims abstract description 18
- 229960000304 folic acid Drugs 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000008439 repair process Effects 0.000 claims abstract description 8
- 235000019441 ethanol Nutrition 0.000 claims description 154
- 230000013020 embryo development Effects 0.000 claims description 30
- 238000011161 development Methods 0.000 claims description 18
- 230000018109 developmental process Effects 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 230000004720 fertilization Effects 0.000 claims description 8
- 230000036542 oxidative stress Effects 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- 241001494479 Pecora Species 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 6
- 230000035764 nutrition Effects 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 5
- 241000282693 Cercopithecidae Species 0.000 claims description 4
- 241000283074 Equus asinus Species 0.000 claims description 4
- 241000283073 Equus caballus Species 0.000 claims description 4
- 241000282326 Felis catus Species 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 210000000472 morula Anatomy 0.000 claims description 4
- 241000283707 Capra Species 0.000 claims description 3
- 230000011987 methylation Effects 0.000 claims description 3
- 238000007069 methylation reaction Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 241001466804 Carnivora Species 0.000 claims description 2
- 241000283153 Cetacea Species 0.000 claims description 2
- 241000288673 Chiroptera Species 0.000 claims description 2
- 241001481833 Coryphaena hippurus Species 0.000 claims description 2
- 241001272567 Hominoidea Species 0.000 claims description 2
- 241000283089 Perissodactyla Species 0.000 claims description 2
- 241000288906 Primates Species 0.000 claims description 2
- 241000283080 Proboscidea <mammal> Species 0.000 claims description 2
- 241000283984 Rodentia Species 0.000 claims description 2
- 241001493546 Suina Species 0.000 claims description 2
- 210000001647 gastrula Anatomy 0.000 claims description 2
- 230000005305 organ development Effects 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 238000010606 normalization Methods 0.000 claims 1
- 239000003513 alkali Substances 0.000 abstract description 10
- 235000021537 Beetroot Nutrition 0.000 abstract 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 53
- 239000004471 Glycine Substances 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- 210000003754 fetus Anatomy 0.000 description 23
- 235000015097 nutrients Nutrition 0.000 description 22
- 210000002459 blastocyst Anatomy 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 19
- 238000005755 formation reaction Methods 0.000 description 18
- 238000002513 implantation Methods 0.000 description 17
- 230000007067 DNA methylation Effects 0.000 description 16
- 239000001963 growth medium Substances 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 14
- 238000000338 in vitro Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 210000002257 embryonic structure Anatomy 0.000 description 10
- 208000014674 injury Diseases 0.000 description 10
- 210000000130 stem cell Anatomy 0.000 description 10
- 239000013589 supplement Substances 0.000 description 10
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000012805 post-processing Methods 0.000 description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000003204 osmotic effect Effects 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 230000011506 response to oxidative stress Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 235000016068 Berberis vulgaris Nutrition 0.000 description 4
- 241000335053 Beta vulgaris Species 0.000 description 4
- 208000033040 Somatoform disorder pregnancy Diseases 0.000 description 4
- 241001122767 Theaceae Species 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 230000006860 carbon metabolism Effects 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 208000032170 Congenital Abnormalities Diseases 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000000625 blastula Anatomy 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000982 limb bud Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000000287 oocyte Anatomy 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000272522 Anas Species 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229960001570 ademetionine Drugs 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000007698 birth defect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000001771 cumulus cell Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002308 embryonic cell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 230000002969 morbid Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- DVOOXRTYGGLORL-VKHMYHEASA-N (2r)-2-(methylamino)-3-sulfanylpropanoic acid Chemical compound CN[C@@H](CS)C(O)=O DVOOXRTYGGLORL-VKHMYHEASA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ACZVSMNFVFBOTM-UHFFFAOYSA-O 2-carboxyethyl(trimethyl)azanium Chemical class C[N+](C)(C)CCC(O)=O ACZVSMNFVFBOTM-UHFFFAOYSA-O 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 101001131994 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) Proline-specific permease Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 1
- 206010016845 Foetal alcohol syndrome Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 206010070531 Foetal growth restriction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 description 1
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 description 1
- 101150028927 Hoxa1 gene Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 101100460719 Mus musculus Noto gene Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000797947 Paria Species 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100024453 Signaling threshold-regulating transmembrane adapter 1 Human genes 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- 229910052564 epsomite Inorganic materials 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 208000026934 fetal alcohol spectrum disease Diseases 0.000 description 1
- 201000007794 fetal alcohol syndrome Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000030941 fetal growth restriction Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 125000003929 folic acid group Chemical group 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 108091035155 miR-10a stem-loop Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000025449 regulation of DNA methylation Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- JWKPKKHJWBZMMT-UHFFFAOYSA-N sodium 4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5-sulfonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-5-hydroxynaphthalene-1-sulfonic acid Chemical compound COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=CC(=C4C=C3)S(=O)(=O)O)N)O)OC)N=NC5=C(C6=C(C=CC(=C6C=C5)S(=O)(=O)O)N)O.[Na+] JWKPKKHJWBZMMT-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000008010 sperm capacitation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000538 tail Anatomy 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000001573 trophoblastic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及甜菜碱在修复乙醇(酒精)对动物胚胎的损伤中的应用。本发明还涉及用甜菜碱修复乙醇(酒精)对动物胚胎的损伤的方法,所述方法包括用治疗有效量的作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合)处理所述胚胎。
Description
技术领域
本发明涉及甜菜碱的一种新医药用途。更具体地,本发明涉及甜菜碱在修复乙醇(酒精)对动物胚胎的损伤中的应用。
背景技术
早期研究表明,高浓度的乙醇会明显影响体细胞和生殖细胞的正常生理状态((Mameli等,2008;Caires等,2012;Luo,2014),尤其是过量摄入乙醇会对如肝脏和心脏等各种组织和器官造成严重损害,并导致癌症的发生(Po¨schl等,2004;Nagy等,2016;Stickel等,2017)。但乙醇是如何影响细胞的仍很难解释清楚,这是因为乙醇会导致多种生理指标、信号传导和基因表达等一系列的变化(Liu等,2015;Ron和Barak,2016;Dorokhov等,2015)。更重要的是,较高浓度的乙醇是致畸因子,会引起一系列胚胎异常变化和缺陷,称为胎儿酒精综合症(FASD)(Astley,2004)。某些情况下,在小鼠卵母细胞研究中使用乙醇作为卵激活的方法之一(Balakier和Casper,1993;Zhang等,2005),并且使用乙醇作为胚胎冻存的保护剂(Martino等,1996)。此外,乙醇还常被用来溶解添加到胚胎培养液中的药物。
在已有研究中,乙醇对胚胎发育的毒性研究受到特别关注。过量的乙醇摄入可引起各种胎儿畸形,这将给幼儿的生命中带来长久的痛苦。同时,乙醇作为表观遗传因素,对身体健康的负面影响可以通过影响生殖细胞或胚胎发育传递到后代。来自急性剂量的实验数据表明,植入前阶段小鼠胚胎受到乙醇影响后,易导致胎儿死亡和胎儿子宫内发育迟缓(Padmanabhan和Hameed,1988)。同时,连续15天摄入10%乙醇会导致囊胚孵化率的显著降低,而且,孕前摄入乙醇会损害滋养层的扩张(Pérez-Tito等,2014)。在体外培养研究中发现,低浓度乙醇与其对胚胎发育的影响之间存在着相关性。例如,低浓度乙醇对猪胚胎发育具有毒性影响,乙醇浓度超过1%的体外成熟(IVM)体系处理卵母细胞时,会导致卵母细胞ROS水平的升高和凋亡相关基因表达的上调(Lee等,2014)。但是尚未发现关于乙醇对小鼠胚胎发育的精确剂量效应的研究。
氧化应激(Oxidative Stress,OS)是指体内氧化与抗氧化作用失衡,倾向于氧化,导致中性粒细胞炎性浸润,蛋白酶分泌增加,产生大量氧化中间产物。氧化应激是由自由基在体内产生的一种负面作用,并被认为是导致衰老和疾病的一个重要因素。乙醇产生的ROS可能破坏蛋白质的结构和性质,并使酶活性发生变化(Sid等,2013)。但这很难解释乙醇影响胚胎发育的途径和机制。在乙醇干扰的所有代谢过程中,叶酸作为甲基供体的一碳代谢受到明显影响(Trimble等,1993;Mason等,2005)。一碳单位来自各种饮食,异常的一碳代谢可能会影响DNA甲基化的过程(Ulrey等,2005)。已有的数据证明乙醇可以干扰依赖叶酸的生化反应(Po¨schl等,2004),抑制叶酸作为供体,由S-腺苷甲硫氨酸(SAM)介导的甲基化过程(Schalinske和Nieman,2005)。小鼠的实验研究表明,乙醇对植入前胚胎的暴露改变了H19印迹控制区(ICR)中DNA甲基化水平(Philip等,2009)。基于乙醇对基因组DNA甲基化的影响和对一碳代谢的干扰的研究结果,进一步的研究发现,通过使用动物模型或体外培养补充叶酸可有助于DNA甲基化的调节并降低潜在的患癌风险(Liu和Ward 2010)。尽管尚不清楚叶酸在调节细胞信号系统和多种代谢(包括核酸和蛋白质)方面起到保护作用,但补充叶酸确实可以阻断乙醇诱导的胎儿畸胎的发生,并有效减轻了实验中乙醇的有害影响,同时预防了神经管缺陷和先天性异常(Gutierrez等,2007),改变了Hoxa1和miR-10a的表达(Wang等,2009)。但叶酸对人体的使用是受到限制的,因为叶酸对细胞和人体生理功能的毒性范围尚不完全清楚。
甜菜碱(Glycine betaine,甘氨酸三甲胺内盐)是一碳代谢循环的另一个甲基供体,广泛分布在动物,植物和微生物中。甜菜碱可从天然植物的根、茎、叶及果实中提取或采用三甲胺和氯乙酸为原料化学合成。甜菜碱的已知用途包括:抗肿瘤,降血压,抗消化性溃疡及胃肠功能障碍,治疗肝脏疾病,作为饲料添加剂具有提供甲基供体功能,可节省部分蛋氨酸,调节体内渗透压,促进脂肪代谢和蛋白质合成,提高瘦肉率等功能。
尽管早期胚胎中的甜菜碱来源还不清楚,但植入前胚胎直到桑葚胚阶段都含有几乎恒定水平的内源性甜菜碱(Corbett等,2014;Anas等,2008)。卵母细胞中的内源性甜菜碱可能部分转运自减数分裂成熟期间的卵丘细胞。SIT1作为甜菜碱/脯氨酸转运蛋白之一,在受精后在小鼠卵中被激活,并且在甜菜碱被转运到卵母细胞直至2-细胞阶段胚胎中起关键作用。另一方面,甜菜碱可能起保护作用,是因为它可以帮助保细胞持正常的渗透压(Stadmiller等,2017),在培养液中加入甜菜碱可能保护胚胎免受渗透压变化所带来的影响(Dawson和Baltz,1997;Anas等,2007)。
发明内容
本发明人经过潜心研究,利用体外培养系统,首先探讨了乙醇浓度梯度对动物(小鼠)胚胎发育的影响,然后出人意料地发现,通过在培养基中加入甜菜碱,能够显著改善受乙醇(酒精)影响的胚胎的发育。此外,本发明人还研究了不同组别处理的囊胚的全基因组DNA甲基化水平的变化。我们的研究结果表明,甜菜碱补充到培养液中可有效改善乙醇处理小鼠胚胎的发育,包括囊胚形成,植入和植入后发育,可将乙醇处理后的囊胚的全基因组DNA的甲基化水平向正常状态修复。所有这些结果表明在辅助生殖治疗及其它有关胚胎损伤修复治疗中,甜菜碱具有较高的应用价值。
因此,在一方面,本发明提供了甜菜碱在预防和/或治疗乙醇(酒精)对动物的损伤中的应用,因此甜菜碱可以用于制备预防和/或治疗乙醇(酒精)对动物的损伤的药物/营养品。
在本发明的一个实施方案中,所述动物为哺乳动物,优选为胎生哺乳动物,更优选选自食肉目(如猫科动物)、啮齿目(如鼠类)、偶蹄目(如猪、牛、羊等)、奇蹄目(如马、驴等)、灵长目(如猴和猿类等)、翼手目(如蝙蝠等)、长鼻目(如象等)和鲸目(如海豚等),最优选选自猫、大鼠、小鼠、豚鼠、猪、牛、羊(山羊/绵羊)、马、驴、猴、猿、狗和人。
在本发明的一个实施方案中,所述动物为受孕动物或所述动物处于胚胎发育阶段(即为动物胚胎),例如为受精、卵裂、桑葚胚、囊胚、原肠胚或器官形成阶段的胚胎。即,所述药物/营养品可以施用于需要辅助生殖治疗及其它有关胚胎损伤修复治疗的受试者。
在本发明的一个实施方案中,所述动物摄入/被暴露于过量乙醇,和/或其中所述甜菜碱能够修复乙醇(酒精)对动物(特别是动物胚胎)的损伤,改善囊胚形成,提高胚胎植入的成功率和植入后的发育,和/或能够将受乙醇(酒精)影响的DNA的囊胚的甲基化水平正常化。
在本发明的一个实施方案中,所述药物作为活性成分仅包含甜菜碱,或还包含其他可以预防和/或治疗乙醇(酒精)导致的不利后果(如胎儿酒精综合征(FASD)、胎儿的神经管缺陷、先天性异常、畸胎等)和/或促进胚胎发育的活性成分(如叶酸)。
在另一方面,本发明提供了甜菜碱在制备改善受乙醇(酒精)损伤的动物胚胎的发育的药物/营养品中的应用。
此外,本发明提供了甜菜碱在制备保护动物胚胎免受乙醇(酒精)损伤的药物/营养品中的应用。
在另一方面,本发明提供了一种用于预防和/或治疗乙醇(酒精)对动物的损伤的药物/营养品,其包含:作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合);和药学/营养学上可接受的辅剂。
在另一方面,本发明提供了一种改善动物胚胎发育的药物/营养品,其包含:作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合);和药学/营养学上可接受的辅剂。
本发明的药物/营养品可以口服服用。例如,以片剂、包衣片剂、糖锭剂、硬和软明胶胶囊、溶液、乳剂或混悬剂形式。然而,也可以通过直肠实现给药,例如,以栓剂的形式,或者经肠胃外给药,例如,以注射液的形式推注或滴注。
术语“药学/营养学上可接受的辅剂”是指在配制药物/营养品中使用的不具有治疗活性并且无毒的任意成分,如稀释剂、崩解剂、粘合剂、填充剂、溶剂、缓冲剂、张度剂、稳定剂、抗氧化剂、表面活性剂或润滑剂。
在还有的另一方面,本发明提供了一种改善动物胚胎发育的方法,所述动物胚胎受氧化应激(由乙醇(酒精)或糖尿病导致的)损伤,所述方法包括用治疗有效量的作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合)处理所述胚胎。所述动物胚胎的发育可以是在体内或体外。在体内胚胎发育的情况下,所述胚胎通过母体摄入甜菜碱;而在体外胚胎发育的情况下,可以将甜菜碱加入到体外胚胎的培养液中。
术语“治疗有效量”意指当被给药于受试者用于治疗疾病状态时,足以实现对于疾病状态的这种治疗的药物的量。“治疗有效量”将依赖于所用药物、所治疗的疾病状态、所治疗的疾病的严重性、受试者的年龄和相对健康状况、给药的途径和形式、主治医师或兽医师的判断以及其他因素而变化。
在本发明的一个具体实施方案中,提供了一种在胚胎体外培养体系中通过补充甜菜碱来修复酒精对胚胎的损伤的方法,所述方法包括用治疗有效量的作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合)处理所述胚胎。
哺乳动物胚胎由于母亲过度摄取乙醇而受到损害,乙醇会导致较高水平的氧化应激反应,并干扰一个碳单位的代谢。本发明中,利用体外培养体系发现乙醇对小鼠胚胎发育的直接作用呈现浓度依赖性。胚胎培养液中使用含有1%的乙醇可显著抑制早期胚胎的发育,并且这种影响会持续整个胚胎在子宫中的发育—包括胚胎着床和植入后发育。但在培养液中添加50μg/ml的甜菜碱能有效地促进乙醇损伤的胚胎发育过程,而添加甘氨酸没有起到类似作用。5-甲基胞嘧啶免疫检荧光测结果表明,补充甜菜碱可以降低1%乙醇引起的小鼠囊胚细胞全基因组DNA甲基化水平,但甘氨酸不能发挥同样的影响。我们的研究结果表明,甜菜碱可能通过恢复囊胚基因组DNA甲基化水平来有效地修复乙醇损伤胚胎的发育。
糖尿病中的胰岛素抵抗与氧化应激关系密切。高游离脂肪酸(FFA)刺激的后果是启动了氧化应激机制(高活性反应分子产生和抗氧化作用之间长期失衡而引起组织损伤)。这些活性分子可直接氧化和损伤DNA、蛋白质、脂类,还可作为功能性分子信号,激活细胞内多种应激敏感信号通路,这些信号通路与胰岛素抵抗和β细胞功能受损密切相关。基于各种(氧化)应激损伤的分子机理具有一定的共性特征(例如,影响DNA甲基化水平),我们推断甜菜碱应该具有较为广泛的修复各种(氧化)应激反应(ROS)造成的胚胎损伤(包括由糖尿病等产生的氧化应激反应(ROS)导致的胚胎损伤)的能力。
附图说明
图1.不同浓度的乙醇对植入前胚胎发育的影响。将精子加入含有卵母细胞的培养基中进行体外受精(IVF),约8小时后获得的原核胚胎(PN),分别在含有不同乙醇浓度的KSOM培养基中培养4天。通过计算囊胚数量与每个处理组中使用的原核胚数量的比例来分析囊胚形成率。数据显示,当浓度为0.5%以上时,乙醇囊胚形成率会明显降低。显示的数据是平均值±SEM;
图2.乙醇和甜菜碱对囊胚形成的影响。将精子加入含有卵母细胞的培养基中进行体外受精(IVF),约8小时后获得的原核胚胎(PN),分别在补充有乙醇或(和)甜菜碱的KSOM培养基中培养4天。分析胚胎发育情况。(A)不同培养基产生的囊胚形态。在(A)中,培养基中没有乙醇或甜菜碱被称为对照组(NC),c和e指乙醇组,其培养基分别含有浓度为1%和1.5%的乙醇,b,d和f表示将甜菜碱以50μg/ml的浓度补充到含有对应于a,c和e的乙醇的培养基中。(B)乙醇和甜菜碱对囊胚形成比例的影响。数据显示,在培养基中乙醇浓度为1%或1.5%时,培养基中甜菜碱的补充可有效恢复乙醇囊泡形成的抑制作用。显示的数据是平均值±SEM。数值在统计学上具有显著差异(p<0.05,*);
图3.乙醇和甜菜碱对囊胚植入的影响。用于移植的囊胚从各个处理组中获得,包括对照组(NC),胚胎培养基中不含乙醇和甜菜碱;甜菜碱组(Bet),胚胎培养基中含有甜菜碱(50μg/ml);乙醇组(Eth),胚胎培养基中含乙醇(v/v 1%);甜菜碱+乙醇组(Eth+Bet),胚胎培养基中含有甜菜碱(50μg/ml)和乙醇(v/v 1%)。在实验中,将十枚囊胚移植到假孕鼠每个子宫的边角中。移植24和30小时后,静脉注射0.1ml 1%芝加哥蓝B,5分钟后检查植入部位,如Paria的工作(Paria BC等人,1993)所述。(A)乙醇或(和)甜菜碱补充培养基对囊胚植入的影响。通过囊胚转移到子宫边角上24小时后注射100μl的1%芝加哥蓝色染料溶液来检查植入部位的表现。(B)定量结果。括号内的数字表示,每组移植囊胚后的蓝色条带数和使用的囊胚总数的百分数。值在统计学上显著不同,p<0.05;
图4.乙醇和甜菜碱对囊胚移植8天后胚胎(胎儿)发育的影响(E11.5)。(A)对照组(NC)胎儿,在移植无任何补充剂的KOSM培养基中培养IVF囊胚4天后获得,它们具有典型的形态发育并具有一定程度的尺寸差异,并根据其大小记录在I类或II类。通过棒状标尺(10mm)来显示刻度。(B)乙醇处理组(Eth)的胎儿,在移植含有1%乙醇的KSOM培养基中培养IVF囊胚的4天后获得。它们显示不同的发育形态,甚至在个体大小上有很大差异,较小的胎儿根据其大小和形状记录在III级。(C)乙醇加甜菜碱处理组(Eth+Bet)的胎儿,在移植含有1%乙醇和50μg/ml甜菜碱的KSOM培养基中培养IVF囊胚4天后获得。这些胎儿的形态学质量与NC组相似。(D)和(E)定量分析乙醇和甜菜碱影响植入后胚胎发育。(D)结果表明,Eth+Bet组中所有胚珠中成形胎儿的百分比可以恢复比Eth组更高的水平(75%vs 61.08%,P>0.05),甚至高于NC组(75%vs 66.07%,P>0.05)。这些数据预示着甜菜碱可能是保护胚胎发育的有效试剂。同样,可以发现(E)甜菜碱可以使Eth+Bet组中I类胎儿的百分比提高到42.11%,而在Eth组中成形的胚珠中仅有20%的I型胎儿,而III类胎儿的数值尽管没有统计学差异,但也不会出现在Eth+Bet组中;
图5.不同浓度乙醇和甘氨酸对囊胚形成的影响。将精子加入含有卵母细胞的培养基中进行体外受精(IVF),约8小时后获得的原核胚胎(PN),分别在无(NC)或含有1%乙醇(Eth),1%乙醇加23μg/ml甘氨酸(Eth+Gly)的KSOM培养基中培养4天,分析胚胎发育情况。数据显示,甘氨酸不能修复乙醇损伤造成的囊胚形成率下降,甚至会明显导致囊胚形成率较低(22.2%)。显示的数据是平均值±SEM。值在统计学上显著不同(p<0.01,**);和
图6.来自含有乙醇,甜菜碱或甘氨酸的培养基的囊胚中DNA甲基化整体水平的分析。(A)不同处理组囊胚中5-MeC免疫荧光的代表性图像,分别来自对照组(NC),无任何补充剂的KOSM培养基中培养IVF原核胚4天后处理获得;乙醇处理组(Eth),在含有1%乙醇的KSOM培养基中培养IVF原核胚4天后处理获得;乙醇加甜菜碱处理组(Eth+Bet),在含有1%乙醇和50μg/ml甜菜碱的KSOM培养基中培养IVF原核胚4天后处理获得;甜菜碱处理组(Bet),在含有50μg/ml甜菜碱的KSOM培养基中培养IVF原核胚4天后处理获得;甘氨酸处理组(Gly),在含有23μg/ml甘氨酸的KSOM培养基中培养IVF原核胚4天后处理获得;乙醇加甘氨酸处理组(Eth+Gly),在含有1%乙醇和23μg/ml甘氨酸的KSOM培养基中培养IVF原核胚4天后处理获得。各组获得的囊胚用5-MeC特异性抗体(绿色)染色,并用PI(红色)复染色统一处理。(B)5-甲基胞嘧啶(5-MeC)整体水平的定量分析。通过将特异性靶标(5-MeC)的强度除以DNA染色(PI)的强度获得荧光强度的平均比例。运用单向ANOVA模型检查处理组之间差异。数值在统计学上具有显著差异,p<0.05。
具体实施方式
下文将参考实施例和附图详细描述本发明,所述实施例仅是意图举例说明本发明,而不是意图限制本发明的范围。本发明的范围由后附的权利要求具体限定。
实施例
材料和方法
除非特别说明,本研究使用的所有化学品都购自西格玛(St.Louis,MO,USA)。
1.动物:
6-8周未合笼的雄性和雌性ICR品系小鼠以及昆明白结扎鼠,均购买自安徽医科大学实验动物中心,安置在笼子里并保持12小时明暗周期,控制温度在21–23℃,自由食用标准饲料和水。尽量减少实验过程中使用的动物数量和实验动物的痛苦。
2.实验设计:
首先,我们研究了胚胎培养液(KSOM培养液,通用的胚胎培养液,成分(g/L):NaCl5.55,KCl 0.19,KH2PO4 0.05,MgSO4·7H2O 0.05,葡萄糖0.04,乳酸钠1.12,NaHCO3 2.1,酚红0.001,丙酮酸钠0.02,CaCl2·2H2O 0.25,EDTA0.004,L-谷氨酰胺0.146,牛血清白蛋白1,试剂全部购自sigma公司)中乙醇的剂量对胚胎发育的影响。将小鼠卵激活当作第0天,通过找出在第4天能完全抑制囊胚形成的乙醇剂量来定义乙醇半抑制剂量。在随后的实验中,将体外受精的胚胎分配加入半抑制剂量乙醇的培养基中培养,同时又分为加入甜菜碱(SigmaB2629-100G,分子量117.15)组和不含甜菜碱组。甘氨酸(G8790-100G)作为无甲基甜菜碱类似物用于参照研究。所有的胚胎在随后的研究都将进行处理。
3.小鼠卵母细胞的制备、体外受精、胚胎培养、胚胎移植:
如前所述,通过48小时内连续注射PMSG和HCG将雌性ICR小鼠进行超数排卵操作(Zhang等,2005)。注射hCG14–16h后从输卵管中收集MII期卵母细胞移入预热的添加4mg/ml的牛血清白蛋白(BSA级分V,Sigma)的M2培养基中。卵丘细胞在37℃含透明质酸酶(0.3mg/ml,Sigma)和BSA的M2培养基中稍作处理,脱去透明带外颗粒细胞。然后将MII卵母细胞在M2+BSA的液滴中清洗三次,转移到覆盖石蜡油的M2+BSA的液滴中等待进一步处理。雌性ICR小鼠通过连续注射超排,IVF在人类输卵管液(HTF)中进行。从成年雄性小鼠附睾尾得到的精子放在37℃环境5%CO2和95%的湿度培养箱中1–2h获能。然后,约预孵育终体积1/10的精子悬液加入卵丘复合体培养基中。精子和卵母细胞共培养3-4H,在人工授精介质中实现受精生殖。
受精卵由是否有两个原核(hCG后22–23h)确定,然后培养在优化培养条件中(KSOM培养液中没有添加氨基酸,Lawitts和Biggers,1993),评估其在体外发育效率。囊胚移植前3天,将至少8周龄的雌性ICR小鼠和昆明白雄性输精管结扎小鼠合笼交配。与结扎雄性小鼠交配的第二天早上,检查雌性小鼠阴道栓,此时计为假孕的第0.5天。根据标准程序在假孕雌数的每侧子宫中移入10枚囊胚。囊胚移植24小时后,通过静脉注射0.1毫升含1%芝加哥蓝染料溶液(Sigma,c8679)的生理盐水,可以清晰观察到着床点。
4.共聚焦显微镜定量分析检测囊胚中DNA甲基化:
先前描述了5-甲基胞嘧啶免疫检测和随后观察的程序,并进行了微小的修改(Beaujean等,2004)。简言之,将胚胎在磷酸盐缓冲盐水(PBS)中洗涤,并在4%多聚甲醛中固定,然后在4℃下储存,直到不同组的胚胎可以同时开展以下步骤。准备好材料后,在进一步处理之前先在PBS中清洗胚胎,并用0.5%Triton X-100将其预处理30分钟,并在室温下用4mol/l HCl处理30分钟。然后用100mmol/l Tris-HCl(pH8.5)处理胚胎20分钟。洗涤数次后,将胚胎在含有1%牛血清白蛋白(1%PBS-BSA)的PBS中在室温下封闭1小时。使用针对5-甲基胞嘧啶的小鼠单克隆抗体(anti-5mC,NA81,Merck,Germany)将甲基化DNA可视化。与该抗体的孵育在4℃下进行过夜(1%PBS-BSA中1:75稀释),然后用1%PBS-BSA洗涤数次,然后在室温下用异硫氰酸荧光素(FITC)缀合的山羊-抗小鼠二抗孵育1小时。在1%PBS-BSA洗涤数次后,37℃下使用染色质用碘化丙啶(PI,10μg/ml)染色15分钟,然后用1%PBS-BSA洗涤数次。将胚胎固定在载玻片上。
使用装备有TCS SP5共聚焦系统(Leica Microsystems,Germany)的立式Optiphot-2显微镜(Nikon,Tokyo,Japan),Nikon Plan ApoX40油浸物镜和488和514nm的激发波长进行观察。通过每个波长的样品以1μm间隔收集串联光学部分(Z系列)。每个颜色通道的收集按顺序进行。对于每个实验,使用相同的智能增益,智能偏移,针孔和变焦参数。对于由每个细胞核发出的积分荧光的定量测量,合并图像的背景通过从整个图像中减去细胞质区域的平均强度来校正。通过手动勾画所有的核来测量核强度。使用Image Pro-Plus软件测量每个单独核发射的总荧光强度,并使用抗5mC信号与PI DNA信号的比率计算每个卵裂球的平均强度。
5.统计分析:
这里,定量数据的所有结果显示为平均值±标准偏差(SD)。所有数据通过单因素方差分析(ANOVA)进行分析,以评估不同组间的任何显着性差异。只有低于0.05的概率被认为是显著的。
结果
1.乙醇对小鼠植入前胚胎发育的影响取决于其在培养液中的浓度
为了研究乙醇在植入前阶段对胚胎发育的直接影响,我们在含有乙醇的培养液中培养IVF卵的原核(PN)胚胎,然后检查其囊胚形成的发育特征。表I中的结果表明,当培养液中乙醇浓度上升到0.5%以上时,乙醇出现了明显抑制小鼠胚胎早期发育的能力。当培养液中乙醇浓度达到2.5%时,所有胚胎被阻滞在4细胞阶段。当乙醇浓度达到1.5%时,囊胚形成的百分比会显着降低到40.3%,当乙醇浓度上升到2.0%时,几乎所有的胚胎都被抑制(图1)。所有这些数据与之前的发现具有一定程度的相似性(Leach RE等,1993)。我们的研究表明,乙醇对囊胚形成的抑制作用依赖于浓度,此外,0.5%和1%乙醇的作用似乎促进了胚胎从2细胞阶段到桑椹胚阶段的发育,尽管其囊胚形成速率明显降低。
除上述试验外,我们也将PN胚胎在含有0.1%乙醇的培养液中培养4天,发现对照组与试验组没有明显的差异,甚至实验组胚胎囊胚的形成率略高于对照组胚胎。以前的研究表明,当培养基乙醇浓度达到10%时,小鼠胚胎的正常发育在2细胞阶段就完全阻滞了。与之对应的,当本研究中乙醇浓度在2.5%时,所有胚胎在2-细胞阶段停止发育。因此,在随后的工作中,我们使用含有1%或1.5%乙醇的KSOM培养基来探究培养液中甜菜碱的补充是否有助于改善乙醇对小鼠胚胎的损伤作用并解释其潜在的机制。
2.甜菜碱可以扭转乙醇对植入前胚胎发育的影响
目前尚不清楚甜菜碱是否可以直接保护胚胎免遭酒精造成的损害。而体外胚胎培养系统能够更好的帮助我们研究甜菜碱对乙醇损伤胚胎发育的直接效应以及其潜在机制。在前期工作中,我们研究了培养液中各种甜菜碱浓度对小鼠胚胎发育的影响,并参考了甜菜碱剂量对动物细胞影响的相关工作结果。结果表明,在单独向培养液中加入50μg/ml甜菜碱的条件下,囊胚的形成速率没有明显变化。随后,我们分析了不同浓度乙醇的到培养液中补加50μg/ml甜菜碱对胚胎发育的影响。图2B中的结果显示,补充50μg/ml甜菜碱到含有1%或1.5%乙醇的培养液中,可有效地改善在其中培养的胚胎的发育状况,囊胚形成比例有着超过10%的增加(p<0.05)(表II)。早期胚胎的形态在所有试验组之间没有明显差异(图2A)。因此,以上数据让我们相信甜菜碱是保护胚胎免受乙醇损害的有效物质。
3.培养液中补充甜菜碱可以促进乙醇损伤囊胚的植入和植入后发育
通过囊胚移植方法分析胚胎植入的能力,以此来判断乙醇对囊胚植入的影响和甜菜碱对此的修复效应。在胚胎移植后24小时,通过注射芝加哥蓝染料来计数囊胚植入的数量,以此来计算囊胚的植入率。结果如图3所示,对照组(NC组)(平均值=83.33%)和甜菜碱组(Bet组)(平均值为87.33%)之间无显着性差异。同时,1%乙醇处理组(Eth组)的囊胚植入率(平均43.83%)明显低于NC组(P<0.01)。尽管Eth组和Eth+Bet组的植入比例差异不具有统计学意义(P=0.06),但后者的囊胚植入率却高达70.00%。
为了评估乙醇对胚胎长期发育的影响,并判断甜菜碱补充到含有乙醇的培养液中是否可以有效促进胚胎植入后发育。我们将包括1%乙醇组(Eth),1%乙醇+50μg/ml甜菜碱组(Eth+Bet)和对照组(NC)中不同组的囊胚移植到假孕鼠的子宫中。8天后,处死移植小鼠并收集子宫以获得胎儿。如图4D所示,在胚胎移植后第8天,收集胚珠并获得具有成形的胎儿,发现在Eth组中,所有胚珠中具有成形胎儿的胚珠比例降至61.08%,但在Eth+Bet组中上升至75%,尽管统计学分析未显示其差异有统计学意义(p>0.05)。根据获得的胎儿的形态和大小特征,三个处理组中的所有成形胎儿可以分为三种类型,分别是I级,II级和III级(图4A,B和C)。I级胎儿呈现正常大小以及形态学特征。II级胎儿呈现一定程度的稍小尺寸,但形态方面未发生明显变化。III级胎儿表现出异常的小体积并且发育明显滞后。图4E的结果表明,将补充50μg/ml甜菜碱到培养液中能够改善乙醇处理囊胚的胎儿发育。1%乙醇处理组(Eth)中I类胎儿的比例降低到20%,而其他处理组中,I型胎儿的平均比例分别是:对照组(NC)中为71.43%(P>0.05)),1%乙醇+50μg/ml甜菜碱组(Eth+Bet)中为42.11%(P>0.05)。III类胎儿只存在于Eth组(10%)。这些结果表明,培养液中补充甜菜碱可有效促进乙醇损伤胚胎的植入后发育。
4.甘氨酸不能修复被乙醇损伤胚胎的发育
甜菜碱是否可以通过调节胚胎细胞的渗透压来改善胚胎的发育。为此,设计以下实验来研究甘氨酸(没有甲基的甜菜碱类似物)是否可以起到同样的修复乙醇损伤胚胎发育的作用。
将甜菜碱替换成甘氨酸加入含有1%乙醇的培养液中培养胚胎。在已有研究中,甘氨酸常被用来探究渗透压和氧化损伤的机制(Cao等,2016;Bhagatte等,2012)。为了做出可比较的判断,采用与50μg/ml的甜菜碱相同的摩尔浓度,在培养液中以32μg/ml的补充甘氨酸。结果如图5所示,甘氨酸无法帮助恢复乙醇损伤小鼠胚胎的发育,甚至明显减少了囊胚形成的比率(p<0.01)。此外,在前期试验中,当甘氨酸浓度超过10μg/ml时,就会产生负面影响。相反,当培养基中甜菜碱的浓度达到500μg/ml时,其对胚胎发育的抑制作用才刚开始出现,这表明甜菜碱可以在较大的浓度范围内安全使用。所有这些数据表明,对胚胎细胞的渗透压保护不是修复乙醇损伤胚胎发育的主要原因。
5.甜菜碱降低乙醇导致的囊胚全基因组DNA的5-MeC水平的升高
囊胚期胚胎的发育状态是确定胚胎植入后发育相关基因表达的关键,它是通过基因组DNA和组蛋白建立表观遗传修饰来进行的,即建立正确的基因组印记和基因表达的再程序化。现在已经知道,DNA甲基化在胚胎发育过程中的基因表达调控中起关键作用,称为基因组印记(Bird A,2002)。胚胎发育过程中囊胚期的全基因组DNA甲基化的重建是十分关键的阶段,同时DNA甲基化水平差异分别呈现于内细胞团(ICM)和滋养外胚层(TE)。
为了确定甜菜碱是否能够帮助修复被乙醇破坏的基因组DNA甲基化修饰,我们用抗5-甲基胞嘧啶(5-MeC)抗体通过免疫荧光方法检测了不同处理组囊胚的基因组DNA甲基化状态。图6中的结果表明,单独补充乙醇(1%)或甜菜碱(50μg/ml)可能导致DNA甲基化整体水平在囊胚的ICM和TE中显著升高,甜菜碱组甚至表现出更高的水平。然而,在Eth+Bet组中,可以发现ICM和TE中的DNA甲基化水平明显下降,这与两组的囊胚形成率类似(平均值=0.88,0.47,P<0.05)。不同的是,使用与本研究中50μg/ml甜菜碱(0.427mM)相同摩尔浓度的甘氨酸加入到无乙醇的培养夜中,也提高了DNA甲基化水平(甘氨酸,32μg/ml等于0.427mM),但不能降低乙醇处理后囊胚中基因组DNA的甲基化水平(P>0.05)。
a数据展示为平均值±标准差
a数据展示为平均值±标准差
以上所述仅为本发明的优选实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
参考文献
Abdelmalek MF,Angulo P,Jorgensen RA,Sylvestre PB,Lindor KD.Betaine,apromising new agent for patients with nonalcoholic steatohepatitis:results ofa pilot study.Am J Gastroenterol.2001;96:2711-2717.
Anas MK,Hammer MA,Lever M,Stanton JA,Baltz JM.The organic osmolytesbetaine and proline are transported by a shared system in earlypreimplantation mouse embryos.J Cell Physiol 2007;210:266-277.
Anas MK,Lee MB,Zhou C,Hammer MA,Slow S,Karmouch J,Liu XJ,LeverM,Baltz JM.SIT1 is a betaine/proline transporter that is activated in mouseeggs after fertilization and functions until the 2-cell stage.Development2008;135:4123-4130.
Astley SJ.Fetal alcohol syndrome prevention in Washington State:evidence of success.Paediatr Perinat Epidemiol 2004;18:344–351.
Balakier H,Casper RF.Experimentally induced parthenogeneticactivation of human oocytes.Hum Reprod 1993;8:740-743.
Barak AJ,Beckenhauer HC,Junnila M,Tuma DJ.Dietary betaine promotesgeneration of hepatic S-adenosylmethionine and protects the liver fromethano-induced fatty infiltration.Alcohol Clin Exp Res 1993;17:552-555.
Beaujean N,Taylor J,Gardner J,Wilmut I,Meehan R,Young L.Effect oflimited DNA methylation reprogramming in the normal sheep embryo on somaticcell nucleartransfer.Biol Reprod 2004;71:185–193.
Bhagatte Y,Lodwick D,Storey N.Mitochondrial ROS production andsubsequent ERK phosphorylation are necessary for temperature preconditioningof isolated ventricular myocytes.Cell Death Dis 2012;3:e345.
Bird A.DNA methylation patterns and epigenetic memory.Genes Dev 2002;16:6–21.
Burgos CF,Guzman L,Aguayo LG.Ethanol effects on glycinergictransmission:From molecular pharmacology to behavior responses.PharmacolRes.2015;101:18-29.
Cao XY,Rose J,Wang SY,Liu Y,Zhao M,Xing MJ,Chang T,Xu B.Glycineincreases preimplantation development of mouse oocytes followingvitrification at the germinal vesicle stage.Sci Rep 2016;6:37262.
Caires KC,Shima CM,de Avila J,McLean DJ.Acute ethanol exposureaffects spermatogonial stem cell homeostasis in pre-pubertal mice.ReprodToxicol 2012;33:76-84.
Corbett HE,DubéCD,Slow S,Lever M,Trasler JM,Baltz JM.Uptake ofbetaine into mouse cumulus-oocyte complexes via the SLC7A6 isoform of y+Ltransporter.Biol Reprod 2014;90:81.
Dawson KM,Baltz JM.Organic osmolytes and embryos:substrates of theGly and beta transport systems protect mouse zygotes against the effects ofraised osmolarity.Biol.Reprod 1997;56:1550–1558.
Dorokhov YL,Shindyapina AV,Sheshukova EV,Komarova TV.Metabolicmethanol:molecular pathways and physiological roles.Physiol Rev 2015;95:603-644.
Gutierrez CM,Ribeiro CN,de Lima GA,Yanaguita MY,Peres LC.Anexperimental study on the effects of ethanol and folic acid deficiency,aloneor in combination,on pregnant Swiss mice.Pathology 2007;39:495-503.
Hamid A,Wani NA,Kaur J.New perspectives on folate transport inrelation to alcoholism-induced folate malabsorption--association withepigenome stability and cancer development.FEBS J 2009;276:2175-2191.
Hammer MA,Baltz JM.Betaine is a highly effective organic osmolyte butdoes not appear to be transported by established organic osmolytetransporters in mouse embryos.Mol Reprod Dev 2002;62:195-202.
Haycock PC,Ramsay M.Exposure of mouse embryos to ethanol duringpreimplantation development:effect on DNA methylation in the h19 imprintingcontrol region.Biol Reprod.2009;81:618-627.
Ji C,Kaplowitz N.Betaine decreases hyperhomocysteinemia,endoplasmicreticulum stress,and liver injury in alcohol-fed mice.Gastroenterology 2003;124:1488-1499.
Kharbanda KK,Rogers DD,Mailliard ME,Siford GL,Barak AJ,BeckenhauerHC,Sorrell MF,Tuma DJ.A comparison of the effects of betaine andSadenosylmethionine on ethanol-induced changes in methionine metabolism andsteatosis in rat hepatocytes.J Nutr 2005;135:519–524.
Kharbanda KK,Todero SL,Ward BW,Cannella JJ,Tuma DJ.Betaineadministration corrects ethanol-induced defective VLDLsecretion.Mol.Cell.Biochem 2009a;327:75–78.Kharbanda KK,Vigneswara V,McVickerBL,Newlaczyl AU,Bailey K,Tuma D,Ray DE,Carter WG.Proteomics reveal aconcerted upregulation of methionine metabolic pathway enzymes,anddownregulation of carbonic anhydrase-III,in betaine supplemented ethanol-fedrats.Biochem Biophys Res Commun 2009b;381:523-527.
Kim SJ,Jung YS,Kwon DY,Kim YC.Alleviation of acute ethanol-inducedliver injury and impaired metabolomics of S-containing substances by betainesupplementation.Biochem.Biophys.Res.Commun 2008;368:893–898.
Lawitts JA,Biggers JD(1993)Culture of preimplantation embryos.MethodsEnzymol 1993;225:153–164.
Leach RE,Stachecki JJ,Armant DR.Development of in vitro fertilizedmouse embryos exposed to ethanol during the preimplantation period:accelerated embryogenesis at subtoxic levels.Teratology 1993;47:57-64.
Lee MB,Kooistra M,Zhang B,Slow S,Fortier AL,Garrow TA,Lever M,TraslerJM,Baltz JM.Betaine homocysteine methyltransferase is active in the mouseblastocyst and promotes inner cell mass development.J Biol Chem 2012;287:33094-33103.
Lee S,Kim E,Hyun SH.Toxicity evaluation of ethanol treatment duringin vitro maturation of porcine oocytes and subsequent embryonic developmentfollowing parthenogenetic activation and in vitro fertilization.Int J Mol Med2014;34:1372-1380.
Liu JJ;Ward RL.Folate and one-carbon metabolism and its impact onaberrant DNA methylation in cancer.Adv Genet 2010;71:79-121.
Liu Y,Chen H,Sun Z,Chen X.Molecular mechanisms of ethanol-associatedoro-esophageal squamous cell carcinoma.Cancer Lett 2015;361:164-73.
Luo J.Autophagy and ethanol neurotoxicity.Autophagy 2014;10:2099-2108.
Mameli M,Botta P,Zamudio PA,Zucca S,Valenzuela CF.Ethanol decreasesPurkinje neuron excitability by increasing GABA release in rat cerebellarslices.J Pharmacol Exp Ther 2008;327:910-917.
Martino A,Songsasen N,Leibo SP.Development into blastocysts of bovineoocytes cryopreserved by ultra-rapid cooling.Biol.Reprod 1996;54:1059-1069.
Mason JB,Choi SW.Effects of alcohol on folate metabolism:implicationsfor carcinogenesis.Alcohol 2005;35:235-241.
Mikami K,Haseba T,Ohno Y.Ethanol induces transient arrest of celldivision(G2+M block)followed by G0/G1 block:dose effects of short-and longer-term ethanol exposure on cell cycle and cell functions.Alcohol Alcohol 1997;32:145-152.
Muralidharan P,Sarmah S,Marrs JA.Zebrafish retinal defects induced byethanol exposure are rescued by retinoic acid and folic acidsupplement.Alcohol 2015;49:149-163.
Nagy LE,Ding WX,Cresci G,Saikia P,Shah VH.Linking PathogenicMechanisms of Alcoholic Liver Disease With ClinicalPhenotypes.Gastroenterology 2016;150:1756-1768.Padmanabhan R,HameedMS.Effects of acute doses of ethanol administered at pre-implantation stageson fetal development in the mouse.Drug Alcohol Depend 1988;22:91-100.
Pauwels S,Ghosh M,Duca RC,Bekaert B,Freson K,Huybrechts I,AS LangieS,Koppen G,Devlieger R,Godderis L.Dietary and supplemental maternal methyl-group donor intake and cord blood DNA methylation.Epigenetics 2017;12:1-10.
Pérez-Tito L,Bevilacqua E,Cebral E.Peri-implantational in vivo and invitro embryo-trophoblast development after perigestational alcohol exposurein the CD-1 mouse.Drug Chem Toxicol 2014;37:184-97.
Stickel F,Wang XD,Seitz HK.Alcohol and cancer:genetic andnutritional aspects.Proc Nutr Soc 2004;63:65-71.
Richards T,Wang F,Liu L,Baltz JM.Rescue of postcompaction-stage mouseembryo development from hypertonicity by amino acid transporter substratesthat may function as organic osmolytes.Biol Reprod 2010;82:769-777.
Ron D,Barak S.Molecular mechanisms underlying alcohol-drinkingbehaviours.Nat Rev Neurosci 2016;17:5765-5791.
Ryan DP,Henzel KS,Pearson BL,Siwek ME,Papazoglou A,Guo L,Paesler K,YuM,Müller R,Xie K,Becker L,Garrett L,SM,Neff F,Rácz I,RathkolbB,Rozman J,Ehninger G,Klingenspor M,KlopstockT,Wolf E,Wurst W,Zimmer A,FuchsH,Gailus-Durner V,Hraběde Angelis M,Sidiropoulou K,Zhou Y,Ehninger D.A.paternal methyl donor-rich diet altered cognitive and neuralfunctions in offspring mice.Mol Psychiatry 2017 Apr 4.doi:10.1038/mp.2017.53.
Santillano DR,Kumar LS,Prock TL,Camarillo C,Tingling JD,MirandaRC.Ethanol induces cell-cycle activity and reduces stem cell diversity toalter both regenerative capacity and differentiation potential of cerebralcortical neuroepithelial precursors.BMC Neurosci 2005;6:59.
Schalinske KL,Nieman KM.Disruption of methyl group metabolism byethanol.Nutr Rev 2005;63:387-391.
Selhub J,Rosenberg IH.Excessive folic acid intake and relation toadverse health outcome.Biochimie 2016;126:71-78.
Sid B,Verrax J,Calderon PB.Role of AMPK activation in oxidative celldamage:Implications for alcohol-induced liver disease.Biochem Pharmacol 2013;86:200-209.
Sogut I,Kanbak G.In vitro effects of ethanol with aspirin on ratbrain synaptosomes:the potential protective role of betaine.Int J Neurosci2010;120:774-783.
Stadmiller SS,Gorensek-Benitez AH,Guseman AJ,Pielak GJ.Osmotic ShockInduced Protein Destabilization in Living Cells and Its Reversal by GlycineBetaine.J Mol Biol 2017;429:1155-1161.
Stickel F,Moreno C,Hampe J,Morgan MY.The genetics of alcoholdependence and alcohol-related liver disease.J Hepatol 2017;66:195-211.
Trimble KC,Molloy AM,Scott JM,Weir DG.The effect of ethanol on one-carbon metabolism:increased methionine catabolism and lipotrope methyl-groupwastage.Hepatology 1993;18:984-989.
Ulrey CL,Liu L,Andrews LG,Tollefsbol TO.The impact of metabolism onDNA methylation.Hum Mol Genet 2005;14 Spec No 1:R139-147.
Wang F,Kooistra M,Lee M,Liu L,Baltz JM.Mouse embryos stressed byphysiological levels of osmolarity become arrested in the late 2-cell stagebefore entry into M phase.Biol Reprod 2011;85:702-713.
Wang LL,Zhang Z,Li Q,Yang R,Pei X,Xu Y,Wang J,Zhou SF,Li Y.Ethanolexposure induces differential microRNA and target gene expression andteratogenic effects which can be suppressed by folic acid supplementation.HumReprod 2009;24:562-579.
Yang J,Cai N,Zhai H,Zhang J,Zhu Y,Zhang L.Natural zwitterionicbetaine enables cells to survive ultrarapid cryopreservation.Sci Rep 2016;6:37458.
Zhang B,Denomme MM,White CR1,Leung KY,Lee MB,Greene ND,Mann MR,Trasler JM,Baltz JM.Both the folate cycle and betaine-homocysteinemethyltransferase contribute methyl groups for DNA methylation in mouseblastocysts.FASEB J 2015;29:1069-1079.
Zhang D,Pan L,Yang LH,He XK,Huang XY,Sun FZ.Strontium promotescalcium oscillations in mouse meiotic oocytes and early embryos through InsP3receptors,and requires activation of phospholipase and the synergistic actionof InsP3.Hum Reprod 2005,20:3053-3061.
Zhao N,Yang S,Hu Y,Dong H,Zhao R.Maternal betaine supplementation inrats induces intergenerational changes in hepatic IGF-1 expression and DNAmethylation.Mol Nutr Food Res 2017;Feb 26.doi:10.1002/mnfr.201600940.
Claims (10)
1.甜菜碱在制备预防和/或治疗乙醇(酒精)对动物的损伤的药物/营养品中的应用。
2.根据权利要求1所述的应用,其中所述动物为哺乳动物,优选为胎生哺乳动物,更优选选自食肉目(如猫科动物)、啮齿目(如鼠类)、偶蹄目(如猪、牛、羊等)、奇蹄目(如马、驴等)、灵长目(如猴和猿类等)、翼手目(如蝙蝠等)、长鼻目(如象等)和鲸目(如海豚等),最优选选自猫、大鼠、小鼠、豚鼠、猪、牛、羊(山羊/绵羊)、马、驴、猴、猿、狗和人。
3.根据权利要求1或2所述的应用,其中所述动物为受孕动物或所述动物处于胚胎发育阶段(即为动物胚胎),例如为受精、卵裂、桑葚胚、囊胚、原肠胚或器官形成阶段的胚胎。
4.根据权利要求1-3中任一项所述的应用,其中所述动物摄入/被暴露于过量乙醇,和/或其中所述甜菜碱能够修复乙醇(酒精)对动物(特别是动物胚胎)的损伤,和/或能够将受乙醇(酒精)影响的DNA的甲基化水平正常化。
5.根据权利要求1-4中任一项所述的应用,其中所述药物作为活性成分仅包含甜菜碱,或还包含叶酸作为活性成分。
6.甜菜碱在制备改善受乙醇(酒精)损伤的动物胚胎的发育的药物/营养品中的应用。
7.甜菜碱在制备保护动物胚胎免受乙醇(酒精)损伤的药物/营养品中的应用。
8.一种用于预防和/或治疗乙醇(酒精)对动物的损伤的药物/营养品,其包含:作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合);和药学/营养学上可接受的辅剂。
9.一种改善动物胚胎发育的药物/营养品,其包含:作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合);和药学/营养学上可接受的辅剂。
10.一种改善动物胚胎发育的方法,所述动物胚胎受(例如由乙醇(酒精)或糖尿病导致的)氧化应激损伤,所述方法包括用治疗有效量的作为活性成分的甜菜碱(任选地,与其他活性成分(如叶酸)组合)处理所述胚胎。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710897319.2A CN107714685A (zh) | 2017-09-28 | 2017-09-28 | 甜菜碱在修复酒精对动物胚胎的损伤中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710897319.2A CN107714685A (zh) | 2017-09-28 | 2017-09-28 | 甜菜碱在修复酒精对动物胚胎的损伤中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107714685A true CN107714685A (zh) | 2018-02-23 |
Family
ID=61208304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710897319.2A Pending CN107714685A (zh) | 2017-09-28 | 2017-09-28 | 甜菜碱在修复酒精对动物胚胎的损伤中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107714685A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112294832A (zh) * | 2020-11-18 | 2021-02-02 | 阜阳师范大学 | 芍药苷的新用途 |
CN113906142A (zh) * | 2019-03-18 | 2022-01-07 | 桑德农业公司 | 植物中基因表达的可编程表观遗传控制 |
CN117783501A (zh) * | 2024-02-26 | 2024-03-29 | 四川大学华西第二医院 | 辛酸钠在注意缺陷与多动障碍中的应用及产品 |
-
2017
- 2017-09-28 CN CN201710897319.2A patent/CN107714685A/zh active Pending
Non-Patent Citations (2)
Title |
---|
KARUNAMUNI ET AL: "Supplementation with the Methyl Donor Betaine Prevents Congenital Defects Induced by Prenatal Alcohol E", 《ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH》 * |
丁芳: "甜菜碱对孕前灌酒雌鼠早期植入前胚胎H3K9乙酰化水平的影响", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113906142A (zh) * | 2019-03-18 | 2022-01-07 | 桑德农业公司 | 植物中基因表达的可编程表观遗传控制 |
CN112294832A (zh) * | 2020-11-18 | 2021-02-02 | 阜阳师范大学 | 芍药苷的新用途 |
CN117783501A (zh) * | 2024-02-26 | 2024-03-29 | 四川大学华西第二医院 | 辛酸钠在注意缺陷与多动障碍中的应用及产品 |
CN117783501B (zh) * | 2024-02-26 | 2024-05-10 | 四川大学华西第二医院 | 辛酸钠在注意缺陷与多动障碍中的应用及产品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van Blerkom et al. | Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy. | |
Songsasen et al. | In vitro growth and steroidogenesis of dog follicles as influenced by the physical and hormonal microenvironment | |
Menegola et al. | Study on the common teratogenic pathway elicited by the fungicides triazole-derivatives | |
Ge et al. | Impaired mitochondrial function in murine oocytes is associated with controlled ovarian hyperstimulationand in vitro maturation | |
Bourne | Biochemistry and physiology of nutrition | |
Roth et al. | The antioxidant epigallocatechin gallate (EGCG) moderates the deleterious effects of maternal hyperthermia on follicle-enclosed oocytes in mice | |
CN107714685A (zh) | 甜菜碱在修复酒精对动物胚胎的损伤中的应用 | |
Boer et al. | Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex | |
Luo et al. | Procyanidin B2 improves oocyte maturation and subsequent development in type 1 diabetic mice by promoting mitochondrial function | |
Abdel-Ghani et al. | Astaxanthin improves the developmental competence of in vitro-grown oocytes and modifies the steroidogenesis of granulosa cells derived from bovine early antral follicles | |
Zander-Fox et al. | Reduction of mitochondrial function by FCCP during mouse cleavage stage embryo culture reduces birth weight and impairs the metabolic health of offspring | |
CN108778296A (zh) | 治疗神经、肌肉和不育疾病或状况的稳定的无定形碳酸钙 | |
Zhang et al. | Supplement of betaine into embryo culture medium can rescue injury effect of ethanol on mouse embryo development | |
Lee et al. | Development of a hamster superovulation program and adverse effects of gonadotropins on microfilament formation during oocyte development | |
JP5552575B2 (ja) | アルツハイマー病治療用医薬の製造におけるα−マンゴスチンの使用 | |
Kuşcu et al. | Myo‐inositol safety in pregnancy: from preimplantation development to newborn animals | |
Shafiei et al. | L-carnitine reduces the adverse effects of ROS and up-regulates the expression of implantation related genes in in vitro developed mouse embryos | |
Leroy et al. | Maternal metabolic health and fertility: we should not only care about but also for the oocyte! | |
Zhang et al. | Beneficial effect and potential molecular mechanism of chloroquine on sperm motility and fertilizing ability in yellow catfish | |
CN117771376B (zh) | 一类化合物在注意缺陷与多动障碍中的应用及产品 | |
Yu et al. | Schisanhenol improves early porcine embryo development by regulating the phosphorylation level of MAPK | |
CN104768614B (zh) | N-乙酰基-l-半胱氨酸在制备治疗体外受精药物中的用途 | |
Jin et al. | Systematic analysis of the factors that adversely affect the rate of cell accumulation in mouse embryos during their culture in vitro | |
Miner et al. | α-synucleinopathy exerts sex-dimorphic effects on the multipurpose DNA repair/redox protein APE1 in mice and humans | |
Liu et al. | Dose-dependent effects of gonadotropin on oocyte developmental competence and apoptosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180223 |